These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1431 related articles for article (PubMed ID: 29497144)

  • 1. The molecular landscape of head and neck cancer.
    Leemans CR; Snijders PJF; Brakenhoff RH
    Nat Rev Cancer; 2018 May; 18(5):269-282. PubMed ID: 29497144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequent HPV-independent p16/INK4A overexpression in head and neck cancer.
    Lechner M; Chakravarthy AR; Walter V; Masterson L; Feber A; Jay A; Weinberger PM; McIndoe RA; Forde CT; Chester K; Kalavrezos N; O'Flynn P; Forster M; Jones TM; Vaz FM; Hayes DN; Fenton TR
    Oral Oncol; 2018 Aug; 83():32-37. PubMed ID: 30098776
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic Typing in Oropharyngeal Squamous Cell Carcinoma: A 4-Year Prospective Practice Study With p16 and High-Risk HPV mRNA Testing Correlation.
    Gondim DD; Haynes W; Wang X; Chernock RD; El-Mofty SK; Lewis JS
    Am J Surg Pathol; 2016 Aug; 40(8):1117-24. PubMed ID: 27035614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of head and neck squamous cell carcinoma.
    Saada-Bouzid E; Peyrade F; Guigay J
    Curr Opin Oncol; 2019 May; 31(3):131-137. PubMed ID: 30893149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolving landscape of HPV-related neoplasia in the head and neck.
    Devins KM; Tetzlaff MT; Baloch Z; LiVolsi VA
    Hum Pathol; 2019 Dec; 94():29-39. PubMed ID: 31654690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P16(INK4A) immunostaining is a strong indicator for high-risk-HPV-associated oropharyngeal carcinomas and dysplasias, but is unreliable to predict low-risk-HPV-infection in head and neck papillomas and laryngeal dysplasias.
    Mooren JJ; Gültekin SE; Straetmans JM; Haesevoets A; Peutz-Kootstra CJ; Huebbers CU; Dienes HP; Wieland U; Ramaekers FC; Kremer B; Speel EJ; Klussmann JP
    Int J Cancer; 2014 May; 134(9):2108-17. PubMed ID: 24127203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Head and neck squamous cell carcinoma: Ambiguous human papillomavirus status, elevated p16, and deleted retinoblastoma 1.
    Beck TN; Smith CH; Flieder DB; Galloway TJ; Ridge JA; Golemis EA; Mehra R
    Head Neck; 2017 Mar; 39(3):E34-E39. PubMed ID: 27859938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p16
    Brauswetter D; Birtalan E; Danos K; Kocsis A; Krenacs T; Timar J; Mihalyi R; Horcsik D; Polony G; Tamas L; Petak I
    Eur Arch Otorhinolaryngol; 2017 Apr; 274(4):1959-1965. PubMed ID: 27999998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative Gene Expression Profiling of Tobacco-Associated HPV-Positive versus Negative Oral Squamous Carcinoma Cell Lines.
    Lepore S; Lettini G; Condelli V; Sisinni L; Piscazzi A; Simeon V; Zoppoli P; Pedicillo MC; Natalicchio MI; Pietrafesa M; Landriscina M
    Int J Med Sci; 2020; 17(1):112-124. PubMed ID: 31929745
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular Patterns and Biology of HPV-Associated HNSCC.
    Brakenhoff RH; Wagner S; Klussmann JP
    Recent Results Cancer Res; 2017; 206():37-56. PubMed ID: 27699528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice.
    Bishop JA; Lewis JS; Rocco JW; Faquin WC
    Semin Diagn Pathol; 2015 Sep; 32(5):344-51. PubMed ID: 25724476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The molecular characteristics of recurrent/metastatic HPV-positive head and neck squamous cell carcinoma: A systematic review of the literature.
    Flach S; Maniam P; Hey SY; Manickavasagam J
    Clin Otolaryngol; 2024 Jul; 49(4):384-403. PubMed ID: 38658385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Basics of tumor development and importance of human papilloma virus (HPV) for head and neck cancer].
    Wittekindt C; Wagner S; Mayer CS; Klußmann JP
    Laryngorhinootologie; 2012 Mar; 91 Suppl 1():S1-26. PubMed ID: 22456913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genomic characterization of head and neck squamous cell carcinoma: Impact and challenges for therapeutic management].
    Saada-Bouzid E; Milano G; Thariat J
    Bull Cancer; 2018 Sep; 105(9):820-829. PubMed ID: 29937334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPV in Head and Neck Carcinomas: Different HPV Profiles in Oropharyngeal Carcinomas - Why?
    Syrjänen S; Syrjänen K
    Acta Cytol; 2019; 63(2):124-142. PubMed ID: 30861518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.
    Haft S; Ren S; Xu G; Mark A; Fisch K; Guo TW; Khan Z; Pang J; Ando M; Liu C; Sakai A; Fukusumi T; Califano JA
    Cancer; 2019 Jul; 125(14):2423-2434. PubMed ID: 30933315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DETECTION OF HUMAN PAPILLOMA VIRUS IN HEAD AND NECK SQUAMOUS CELL CARCINOMAS: A LITERATURE REVIEW.
    Jelihovschi I; Bidescu AC; Tucaliuc SE; Iancu LS
    Rev Med Chir Soc Med Nat Iasi; 2015; 119(2):502-9. PubMed ID: 26204659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a head and neck cancer-derived cell line panel confirms the distinct TP53-proficient copy number-silent subclass.
    van Harten AM; Poell JB; Buijze M; Brink A; Wells SI; René Leemans C; Wolthuis RMF; Brakenhoff RH
    Oral Oncol; 2019 Nov; 98():53-61. PubMed ID: 31541927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 72.